UnknownEarly Phase 1

Study Designed to Optimize the Treatment of Primary Pneumothorax

Denmark300 participantsStarted 2009-03

Plain-language summary

Knowledge about incidence, risk factors and genetic predispositions of primary spontaneous pneumothorax in young adults is very limited, and treatment has also been controversial.The Aim of this study is to optimize the treatment, estimate the actual incidence, and identify possible risk factors including genetic predispositions.

Who can participate

Age range18 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * First incidence of primary spontaneous pneumothorax. * Age between 18 and 40. * No known preexisting pulmonary disease. * Patient must accept randomization. * Able to read and understand information regarding the study. * The condition must require treatment with a chest-tube. Exclusion Criteria: * Age above 40. * Previously pulmonary og cardiac surgery. * Pregnant or breastfeeding. * Patients who do not tolerate anesthetics.

What they're measuring

Time to ipsilateral recurrence

Timeframe: 10 years

Trial details

NCT IDNCT02866305

SponsorOdense University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12

Contact for this trial

Winnie Hedevang Olesen, ph.d.student

0045-22947131 winnie.olesen@rsyd.dk

View on ClinicalTrials.gov More Primary Spontaneous Pneumothorax trials